Skip to main content
EW logo
EW
(NYSE)
Edwards Lifesciences Corporation
$82.97-- (--)
Loading... - Market loading

Edwards Lifesciences (EW) Company Profile

Complete business overview, executive team, trading details, and corporate information.

Edwards Lifesciences Corporation
EWNew York Stock Exchange

About Edwards Lifesciences

Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. It distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Company Information

CEOBernard Zovighian
Founded1958
Employees16,000
CountryUnited States
Fiscal YearJanuary - December

Stock Details

ExchangeNew York Stock Exchange (NYSE)
CurrencyUSD - USD
TypeStock
SubtypeCommon Stock

Contact Information

Phone949 250 2500
Address
One Edwards Way Irvine, California 92614 United States

Corporate Identifiers

CUSIP28176E108
ISINUS28176E1082
SIC3842

Leadership Team & Key Executives

Bernard Zovighian
Chief Executive Officer
Scott Ullem
Chief Financial Officer
Joseph Nuzzolese
Chief Operating Officer